Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

New Sequencing Tech May Slash Time and Cost

December 21, 2010 6:14 am | News | Comments

Scientists from Imperial College London are developing technology that could ultimately sequence a person's genome in mere minutes, at a fraction of the cost of current commercial techniques.


New Thinking on Origins of Liver Disease

December 21, 2010 6:12 am | News | Comments

In the latest of a series of related papers, researchers present a new and more definitive explanation of how fibrotic cells form, multiply and eventually destroy the human liver, resulting in cirrhosis.


Herbal Supplement Little Help Stopping Colds

December 21, 2010 6:09 am | News | Comments

An over-the-counter herbal treatment believed to have medicinal benefits has minimal impact in relieving the common cold, according to research by the University of Wisconsin-Madison School of Medicine and Public Health.


Cyclacel Drug Increases Median Overall Survival

December 21, 2010 6:05 am | News | Comments

Cyclacel Pharmaceuticals, Inc. provided topline results from APPRAISE, a Phase 2b, randomized discontinuation, double-blinded, placebo-controlled, study of oral seliciclib capsules as a third or more line treatment in patients with non-small cell lung cancer.


VBL Begins Phase 2 VB-201 Trial

December 21, 2010 6:02 am | News | Comments

VBL Therapeutics announced the initiation of a phase 2 study to evaluate the efficacy and safety of its lead compound, VB-201, among patients with elevated high sensitivity C-reactive protein who are currently taking statins.


Vivus Asks EMA for Qnexa Approval

December 21, 2010 5:58 am | News | Comments

Vivus Inc. said it asked European regulators to approve its weight-loss drug Qnexa, which has already been rejected by U.S. regulators because of concerns over links to potential heart problems and birth defects.


Incyte Blood Cancer Drug Performs Well

December 21, 2010 5:57 am | News | Comments

Incyte Corp. said its primary drug candidate succeeded in a late-stage clinical trial that tested the drug as a treatment for myelofibrosis, a cancer of the blood.


AstraZeneca Halts Motavizumab for RSV

December 21, 2010 5:55 am | News | Comments

AstraZeneca PLC said it has stopped development of its drug motavizumab for preventing serious respiratory syncytial virus disease but would continue working on other applications.


Pfizer Recalls More Lipitor Bottles

December 21, 2010 5:53 am | News | Comments

Drug developer Pfizer Inc. recalled a batch of 19,000 bottles of the blockbuster cholesterol drug Lipitor, citing a consumer complaint about an "uncharacteristic" odor.


FDA Accelerates Review of Florbetapir

December 21, 2010 5:52 am | News | Comments

Eli Lilly and Co. has completed its purchase of Avid Radiopharmaceuticals Inc. for $300 million and said the Food and Drug Administration will perform a faster review of florbetapir, an imaging agent Avid developed that may help diagnose Alzheimer's disease.


PharmaNet Offering Biosimilar Guidance

December 20, 2010 9:18 am | News | Comments

PharmaNet Development Group, Inc. announced that its regulatory and pharmaceutical development experts are available to offer guidance on the regulatory pathway for biosimilar development in the United States, following a recent FDA hearing.


In Vivo Microscope

December 20, 2010 7:26 am | Product Releases | Comments

The integration of the Coherent Chameleon Compact OPO with the Leica TCS SP5 MP confocal and multiphoton microscope allows observation of fast dynamic processes in living cells with deep penetration at high resolution with one integrated microscope system.


Semiconducting Gene Sequencer

December 20, 2010 7:18 am | Drug Discovery & Development | Product Releases | Comments

Life Technologies Corporation, a provider of innovative life science solutions, announced that it has launched its Ion Personal Genome Machine (PGM) sequencer, the first product to use semiconductor sequencing technology.


Teva Leading Generic Company in Europe

December 20, 2010 7:09 am | News | Comments

Teva Pharmaceutical Industries Ltd. announced that it has completed the acquisition of ratiopharm, Germany's second largest generics producer. Following the acquisition, Teva is the number one generic company in Europe.


J & J Loses Price Fixing Case

December 20, 2010 6:49 am | News | Comments

Johnson & Johnson must pay $52 million in damages and penalties after a Pennsylvania judge found the pharmaceutical company falsely reported the prices of its drugs.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.